Is coronary artery calcification at the intersection of vitamin D and coronary artery disease?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 12, 2010, Pages 2329-2330

  Dastani, Zari ^a   Richards, J Brent ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

atherosclerosis; calcification; calcium; coronary artery disease; vitamin D

Indexed keywords

VITAMIN D;

ARTERY CALCIFICATION; ATHEROSCLEROSIS; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; EDITORIAL; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; CALCINOSIS; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RISK ASSESSMENT; RISK FACTORS; STEROID HYDROXYLASES; UNITED STATES; VITAMIN D;

EID: 78650381978     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.216218     Document Type: Editorial

References (18)

1. Castelli WP. Epidemiology of coronary heart disease: The framingham study. Am J Med. 1984;76:4-12.
2. Levin A, Li YC. Vitamin d and its analogues: Do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005; 68:1973-1981.
3. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210-215.
4. Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O'Malley PG. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: Mean three-year outcomes in the prospective army coronary calcium (pacc) project. Journal of the American College of Cardiology. 2005;46:807-814.
5. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL. Active serum vitamin d levels are inversely correlated with coronary calcification. Circulation. 1997;96:1755-1760.
6. Shen H, Bielak LF, Ferguson JF, Streeten EA, Yerges-Armstrong LM, Liu J, Post W, O'Connell JR, Hixson JE, Kardia SL, Sun YV, Jhun MA, Wang X, Mehta NN, Li M, Koller DL, Hakonarson H, Keating BJ, Rader DJ, Shuldiner AR, Peyser PA, Reilly MP, Mitchell BD. Association of the vitamin d metabolism gene cyp24a1 with coronary artery calcification. Arterioscler Thromb Vasc Biol. 2010.
7. Tashiro K, Abe T, Oue N, Yasui W, Ryoji M. Characterization of vitamin d-mediated induction of the cyp 24 transcription. Mol Cell Endocrinol. 2004;226:27-32.
8. Ponchon G, Kennan AL, DeLuca HF. "Activation" Of vitamin d by the liver. J Clin Invest. 1969;48:2032-2037.
9. Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S. 25-hydroxyvitamin d3 1alpha-hydroxylase and vitamin d synthesis. Science. 1997;277:1827-1830.
10. Kasuga H, Hosogane N, Matsuoka K, Mori I, Sakura Y, Shimakawa K, Shinki T, Suda T, Taketomi S. Characterization of transgenic rats con-stitutively expressing vitamin d-24-hydroxylase gene. Biochem Biophys Res Commun. 2002;297:1332-1338.
11. Psaty BM, O'Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, Uitterlinden AG, Harris TB, Witteman JC, Boerwinkle E. Cohorts for heart and aging research in genomic epidemiology (charge) consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2:73-80.
12. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, Proctor BM, Petty M, Chen Z, Schechtman KB, Bernal-Mizrachi L, Bernal-Mizrachi C. 1,25(oh)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009;120:687-698.
13. Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin d decreases nfkappab activity by increasing ikappabalpha levels. Nephrol Dial Transplant. 2006;21:889-897.
14. Sepulveda JL, Mehta JL. C-reactive protein and cardiovascular disease: A critical appraisal. Curr Opin Cardiol. 2005;20:407-416.
15. McCarty MF. Secondary hyperparathyroidism promotes the acute phase response - a rationale for supplemental vitamin d in prevention of vascular events in the elderly. Med Hypotheses. 2005;64:1022-1026.
16. Holick MF. High prevalence of vitamin d inadequacy and implications for health. Mayo Clin Proc. 2006;81:353-373.
17. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-dihydroxyvitamin d(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-238.
18. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin d levels and risk of incident hypertension among young women. Hypertension. 2008;52:828-832.